On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.

Prof. Paul L. DeAngelis University of Oklahoma, USA, Caisson Biotech LLC, USA and Hyalose LLC, USA
1 TalkBiography
Paul L. DeAngelis, PhD, is a glycobiology researcher exploring and harnessing glycosaminoglycan [GAG] biosynthesis. He received his undergraduate training at Harvard University and his PhD from the University of California, Irvine. Since 1981glycobiology has been his research focus, from 1998-2004 his academic team at University of Oklahoma Health Sciences Center... read morediscovered a variety of enzymes that polymerize GAG polymers. Between 2000-2009 he started four biotech companies in commercializing recombinant GAG products. Paul's current interest is creating GAG-based therapeutics using chemoenzymatic synthesis.